Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial

<strong>Background</strong> The long-term effects of (OPCAB) continue to be controversial as some studies have reported increased adverse event rates with OPCAB when compared to on-pump coronary artery bypass (ONCAB). The Arterial Revascularization Trial (ART) compared survival after bil...

Full description

Bibliographic Details
Main Authors: Benedetto, U, Altman, D, Gerry, S, Gray, A, Lees, B, Flather, M, Taggart, D, on behalf of the ART investigators
Format: Journal article
Published: Elsevier 2017
_version_ 1797075696599695360
author Benedetto, U
Altman, D
Gerry, S
Gray, A
Lees, B
Flather, M
Taggart, D
on behalf of the ART investigators
author_facet Benedetto, U
Altman, D
Gerry, S
Gray, A
Lees, B
Flather, M
Taggart, D
on behalf of the ART investigators
author_sort Benedetto, U
collection OXFORD
description <strong>Background</strong> The long-term effects of (OPCAB) continue to be controversial as some studies have reported increased adverse event rates with OPCAB when compared to on-pump coronary artery bypass (ONCAB). The Arterial Revascularization Trial (ART) compared survival after bilateral versus single internal thoracic artery grafting. The choice of OPCAB versus ONCAB was based on surgeon’s discretion. We performed a post-hoc analysis of the ART to compare 5-year outcomes with two strategies. <strong>Methods</strong> Among 3102 patients enrolled in the ART, we selected 1260 patients who underwent OPCAB versus 1700 patients who underwent ONCAB with cardioplegic arrest for the preent comparison. Primary outcomes were 5-year mortality and incidence of major cardiac and cerebrovascular events (MACCE) including cardiovascular death, myocardial infarction, cerebrovascular accident and revascularization after index procedure. Propensity score matching selected 1260 pairs for final comparison. Stratified Cox models were used for treatment effect estimate. <strong>Results</strong> Hospital mortality was comparable between OPCAB and ONCAB groups (12[1.0%] vs 15[1.2%]; P=0.7). Conversion rate to on pump during OPCAB was 29/1260 (2.3%). When compared to OPCAB not converted, OPCAB converted to on-pump presented a remarkably higher hospital mortality (10.3% vs 0.7%; P&lt;0.001). At 5 years, mortality rate was 110(8.9%) vs. 102(8.3%) in the OPCAB and ONCAB groups respectively with no significant difference (hazard ratio, HR 1.14; 95% confidence interval, CI 0.86-1.52; P=0.35). Incidence of MACCE was 175(14.3) vs. 169 (13.8) in the in the OPCAB and ONCAB groups respectively with no significant difference (HR 1.05; 95%CI 0.84-1.31; P=0.65). <strong>Conclusions</strong> The present post-hoc ART analysis supports the hypothesis that both OPCAB and ONCAB are equally effective and safe.
first_indexed 2024-03-06T23:53:55Z
format Journal article
id oxford-uuid:738da3b2-736c-4b0a-85f7-0ad6cf5dc190
institution University of Oxford
last_indexed 2024-03-06T23:53:55Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling oxford-uuid:738da3b2-736c-4b0a-85f7-0ad6cf5dc1902022-03-26T19:57:11ZOff-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization TrialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:738da3b2-736c-4b0a-85f7-0ad6cf5dc190Symplectic Elements at OxfordElsevier2017Benedetto, UAltman, DGerry, SGray, ALees, BFlather, MTaggart, Don behalf of the ART investigators<strong>Background</strong> The long-term effects of (OPCAB) continue to be controversial as some studies have reported increased adverse event rates with OPCAB when compared to on-pump coronary artery bypass (ONCAB). The Arterial Revascularization Trial (ART) compared survival after bilateral versus single internal thoracic artery grafting. The choice of OPCAB versus ONCAB was based on surgeon’s discretion. We performed a post-hoc analysis of the ART to compare 5-year outcomes with two strategies. <strong>Methods</strong> Among 3102 patients enrolled in the ART, we selected 1260 patients who underwent OPCAB versus 1700 patients who underwent ONCAB with cardioplegic arrest for the preent comparison. Primary outcomes were 5-year mortality and incidence of major cardiac and cerebrovascular events (MACCE) including cardiovascular death, myocardial infarction, cerebrovascular accident and revascularization after index procedure. Propensity score matching selected 1260 pairs for final comparison. Stratified Cox models were used for treatment effect estimate. <strong>Results</strong> Hospital mortality was comparable between OPCAB and ONCAB groups (12[1.0%] vs 15[1.2%]; P=0.7). Conversion rate to on pump during OPCAB was 29/1260 (2.3%). When compared to OPCAB not converted, OPCAB converted to on-pump presented a remarkably higher hospital mortality (10.3% vs 0.7%; P&lt;0.001). At 5 years, mortality rate was 110(8.9%) vs. 102(8.3%) in the OPCAB and ONCAB groups respectively with no significant difference (hazard ratio, HR 1.14; 95% confidence interval, CI 0.86-1.52; P=0.35). Incidence of MACCE was 175(14.3) vs. 169 (13.8) in the in the OPCAB and ONCAB groups respectively with no significant difference (HR 1.05; 95%CI 0.84-1.31; P=0.65). <strong>Conclusions</strong> The present post-hoc ART analysis supports the hypothesis that both OPCAB and ONCAB are equally effective and safe.
spellingShingle Benedetto, U
Altman, D
Gerry, S
Gray, A
Lees, B
Flather, M
Taggart, D
on behalf of the ART investigators
Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title_full Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title_fullStr Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title_full_unstemmed Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title_short Off-pump versus on-pump coronary artery bypass grafting. Insights from the Arterial Revascularization Trial
title_sort off pump versus on pump coronary artery bypass grafting insights from the arterial revascularization trial
work_keys_str_mv AT benedettou offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT altmand offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT gerrys offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT graya offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT leesb offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT flatherm offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT taggartd offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial
AT onbehalfoftheartinvestigators offpumpversusonpumpcoronaryarterybypassgraftinginsightsfromthearterialrevascularizationtrial